Exploring the Presence of Leishmania RNA Virus 1 in Leishmania (Viannia) braziliensis isolates from the most endemic area of American Tegumentary Leishmaniasis in Argentina.

Mar��a Cristina Almaz��n, Gabriela Gonz��lez-Prieto, Luiza de Oliveira R Pereira, Melisa D��az-Fern��ndez, Guillermo Portal, Lilian Motta Cantanh��de, Fernanda Garc��a-Bustos, Cecilia Parodi, Pamela Cajal, Marcelo Quipildor, Julio Nasser, Alejandro Krolewiecki, Alejandra Barrio
Author Information
  1. Mar��a Cristina Almaz��n: Instituto de Investigaciones de Enfermedades Tropicales, Facultad Regional Or��n, Universidad Nacional de Salta, Or��n, Argentina.
  2. Gabriela Gonz��lez-Prieto: Laboratorio de Microbiolog��a, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Salta, Argentina.
  3. Luiza de Oliveira R Pereira: Funda����o Oswaldo Cruz, Instituto Oswaldo Cruz, Laborat��rio de Pesquisa em Leishmanioses, Rio de Janeiro, RJ, Brasil.
  4. Melisa D��az-Fern��ndez: Instituto de Investigaciones de Enfermedades Tropicales, Facultad Regional Or��n, Universidad Nacional de Salta, Or��n, Argentina.
  5. Guillermo Portal: Instituto de Investigaciones de Enfermedades Tropicales, Facultad Regional Or��n, Universidad Nacional de Salta, Or��n, Argentina.
  6. Lilian Motta Cantanh��de: Funda����o Oswaldo Cruz, Instituto Oswaldo Cruz, Laborat��rio de Pesquisa em Leishmanioses, Rio de Janeiro, RJ, Brasil.
  7. Fernanda Garc��a-Bustos: Instituto de Patolog��a Experimental, Consejo Nacional de Investigaciones Cient��ficas y T��cnicas, Salta, Argentina.
  8. Cecilia Parodi: Instituto de Patolog��a Experimental, Consejo Nacional de Investigaciones Cient��ficas y T��cnicas, Salta, Argentina.
  9. Pamela Cajal: Instituto de Investigaciones de Enfermedades Tropicales, Facultad Regional Or��n, Universidad Nacional de Salta, Or��n, Argentina.
  10. Marcelo Quipildor: Instituto de Investigaciones de Enfermedades Tropicales, Facultad Regional Or��n, Universidad Nacional de Salta, Or��n, Argentina.
  11. Julio Nasser: C��tedra de Qu��mica Biol��gica, Facultad de Ciencias Naturales, Universidad Nacional de Salta, Salta, Argentina.
  12. Alejandro Krolewiecki: Instituto de Investigaciones de Enfermedades Tropicales, Facultad Regional Or��n, Universidad Nacional de Salta, Or��n, Argentina; Mundo Sano, Buenos Aires, Argentina.
  13. Alejandra Barrio: Laboratorio de Microbiolog��a, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Salta, Argentina. Electronic address: aleba05@yahoo.com.ar.

Abstract

American Tegumentary Leishmaniasis (ATL) comprises a group of diseases caused by protozoan parasites of the Leishmania genus. The endosymbiont Leishmania RNA Virus 1 (LRV1) has been associated with severe disease forms and treatment failure in several South American countries; however, no data are available for Argentina. This study conducted the first screening for LRV1 in the country's most endemic region, Salta Province, analyzing 44 clinical samples from cutaneous, mucosal, and relapsing ATL cases. All samples were identified as Leishmania (Viannia) braziliensis by PCR-RFLP, and tested negative for LRV1 using RT-PCR. Applying a zero-patient design to avoid concluding absolute absence, the theoretical LRV1 prevalence was estimated to be below 7%, substantially lower than the 25-77% range reported in Amazonian regions. These findings suggest that LRV1 distribution may not extend into Argentina. While LRV1 may contribute to disease severity when present, it should not be regarded as an exclusive or definitive factor in clinical presentation or therapeutic response in the region. Further research into genetic, immunological, and epidemiological factors is needed to better understand severe ATL forms in Argentina and to develop targeted strategies for improved disease management.

Keywords

Word Cloud

Created with Highcharts 10.0.0LeishmaniaLRV1ArgentinaAmericanLeishmaniasisTegumentaryATLRNA1diseaseVianniabraziliensisVirussevereformsendemicregionclinicalsamplesmaycomprisesgroupdiseasescausedprotozoanparasitesgenusendosymbiontassociatedtreatmentfailureseveralSouthcountrieshoweverdataavailablestudyconductedfirstscreeningcountry'sSaltaProvinceanalyzing44cutaneousmucosalrelapsingcasesidentifiedPCR-RFLPtestednegativeusingRT-PCRApplyingzero-patientdesignavoidconcludingabsoluteabsencetheoreticalprevalenceestimated7%substantiallylower25-77%rangereportedAmazonianregionsfindingssuggestdistributionextendcontributeseveritypresentregardedexclusivedefinitivefactorpresentationtherapeuticresponseresearchgeneticimmunologicalepidemiologicalfactorsneededbetterunderstanddeveloptargetedstrategiesimprovedmanagementExploringPresenceisolatesareavirusMucosal

Similar Articles

Cited By